Veterinary Research Forum

Effects of salbutamol on the physiological, electrocardiographic, and echocardiographic variables of healthy cats

Document Type : Original Article

Authors

Arash Azadi 1
Reza Avizeh 1
Mahdi Pourmahdi Borujeni 2
Abdolrazagh Rostami 3

1 Department of Clinical Sciences, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

2 Department of Food Hygiene, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

3 Tabesh Veterinary Radiology Center, Tehran, Iran

10.30466/vrf.2026.2070329.4896
Abstract
Salbutamol is a primary bronchodilator for feline asthma management. However, comprehensive data on its cardiovascular safety in cats are limited despite its widespread clinical use. This study aimed to characterize the acute cardiovascular and respiratory responses following nebulized salbutamol administration in healthy feline subjects, with an emphasis on clinical safety assessment. Twenty healthy adult cats received nebulized salbutamol (3.75 mg per 20 min). A comprehensive cardiovascular evaluation, including vital signs monitoring, electrocardiography, and echocardiography, was performed before and 15 min after treatment. Salbutamol administration was associated with minimal physiological alterations. Heart rate increased from a mean of 204.10 ± 33.09 to 218.35 ± 4.84 beats per min. The E-wave/A-wave ratio increased from 2.44 ± 0.33 to 3.05 ± 0.56. Normal sinus rhythm was maintained in all subjects (100%). Sinus tachycardia was observed in 65.00% of cats, transient PR interval shortening in 25.00%, and isolated premature atrial contractions in 15.00%. No pathological arrhythmias or significant conduction blocks were detected. Respiratory rate showed a minor increase from 38.05 ± 5.87 to 40.05 ± 5.96 breaths/min, while blood pressure and body temperature remained stable. Nebulized salbutamol demonstrates a high margin of cardiovascular safety in healthy cats. The preservation of normal sinus rhythm and clinically insignificant nature of the observed physiological changes support its continued use as a first-line bronchodilator in feline respiratory medicine.

Keywords

Beta-2 agonist
Cardiovascular safety
Echocardiography
Electrocardiography
Feline asthma
Subjects
1.     Trzil JE, Reinero CR. Update on feline asthma. Vet Clin North Am Small Anim Pract 2014; 44(1): 91-105.
2.     Cocayne CG, Reinero CR, DeClue AE. Subclinical airway inflammation despite high-dose oral corticosteroid therapy in cats with lower airway disease. J Feline Med Surg 2011; 13(8): 558-563.
3.     Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation. Chest 2002; 121(6): 1977-1987.
4.     Galler A, Shibly S, Bilek A, et al. Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis). J Small Anim Pract 2013; 54(10): 531-536.
5.     Padrid P. Feline asthma. Diagnosis and treatment. Vet Clin North Am Small Anim Pract 2000; 30(6): 1279-1293.
6.     Dye JA, McKiernan BC, Rozanski EA, et al. Broncho-pulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. J Vet Intern Med 1996; 10(6): 385-400.
7.     Adamama-Moraitou KK, Patsikas MN, Koutinas AF. Feline lower airway disease: a retrospective study of 22 naturally occurring cases from Greece. J Feline Med Surg 2004; 6(4): 227-233.
8.     Byers CG, Dhupa N. Feline bronchial asthma: pathophysiology and treatment. Compend Contin Educ Vet 2005; 27(6): 418-425.
9.     Venema CM, Patterson CC. Feline asthma: what’s new and where might clinical practice be heading? J Feline Med Surg 2010; 12(9): 681-692.
10. Johnson M, Rennard S. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest 2001; 120(1): 258-270.
11. Ramsey I. BSAVA small animal formulary. 11th ed. Gloucester, UK: British Small Animal Veterinary Association 2023; 333-334.
12. Plumb DC. Plumb’s veterinary drug handbook: desk ed. Hoboken, USA: John Wiley & Sons 2018; 51-53.
13. Bowman WC, Nott MW. Actions of sympathomimetic amines and their antagonists on skeletal muscle. Pharmacol Rev 1969; 21(1): 27-72.
14. Barnes PJ. Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells. Life Sci 1993; 52(26): 2101-2119.
15. Payne JR, Brodbelt DC, Luis Fuentes V. Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol 2015; 17(Suppl 1): S244-S257.
16. Chetboul V, Tissier R. Echocardiographic assessment of canine degenerative mitral valve disease. J Vet Cardiol 2012; 14(1): 127-148.
17. Schober KE, Chetboul V. Echocardiographic evaluation of left ventricular diastolic function in cats: hemodynamic determinants and pattern recognition. J Vet Cardiol 2015; 17(Suppl 1): S102-S133.
18. Bright JM, Herrtage ME, Schneider JF. Pulsed Doppler assessment of left ventricular diastolic function in normal and cardiomyopathic cats. J Am Anim Hosp Assoc 1999; 35(4): 285-291.
19. Paige CF, Abbott JA, Elvinger F, et al. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009; 234(11): 1398-1403.
20. Häggström J, Luis Fuentes V, Wess G. Screening for hypertrophic cardiomyopathy in cats. J Vet Cardiol 2015; 17(Suppl 1): S134-S149.
21. Tilley LP, Smith FW, Oyama MA, et al. Manual of canine and feline cardiology. 5th ed. St. Louis, USA: Elsevier Saunders 2016; 31-33.
22. Côté E, Jaeger R. Ventricular tachyarrhythmias in 106 cats: associated structural cardiac disorders. J Vet Intern Med 2008; 22(6): 1444-1446.
23. Spalla I, Locatelli C, Riscazzi G, et al. Survival in cats with primary and secondary cardiomyopathies. J Feline Med Surg 2016; 18(6): 501-509.
24. Fox PR, Oyama MA, Reynolds C, et al. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats. J Vet Cardiol 2009; 11(Suppl 1): S51-S61.
25. Ward JL, Lisciandro GR, Ware WA, et al. Evaluation of point-of-care thoracic ultrasound and NT-proBNP for the diagnosis of congestive heart failure in cats with respiratory distress. J Vet Intern Med 2018; 32(5): 1530-1540.
26. Côté E, MacDonald KA, Meurs KM, et al. Feline cardiology. Hoboken, USA: Wiley-Blackwell 2011; 419-420.
27. Daly MJ, Farmer JB, Levy GP. Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs. Br J Pharmacol 1971; 43(3): 624-638.
28. Salvà A, Juette T, Letendre JA. Effect of inhaled salbutamol on whole-blood potassium concentrations in healthy cats. J Feline Med Surg 2025; 27(4): 098 612X251320297. doi: 10.1177/1098612X251320297.
29. Luis Fuentes V, Abbott J, Chetboul V, et al. ACVIM consensus statement guidelines for the classification, diagnosis, and management of cardiomyopathies in cats. J Vet Intern Med 2020; 34(3): 1062-1077.
30. Fox PR, Keene BW, Lamb K, et al. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: the REVEAL study. J Vet Intern Med 2018; 32(3): 930-943.
31. Leemans J, Kirschvink N, Bernaerts F, et al. A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. Vet J 2009; 180(2): 236-245.
32. Boon JA. Veterinary echocardiography. 2nd ed. Ames, USA: Wiley-Blackwell 2011; 30.
33. Boon JA. Doppler echocardiography for the small animal practitioner. Hoboken, USA: John Wiley & Sons 2023; 3-14.
34. MacDonald KA. Congenital heart diseases of puppies and kittens. Vet Clin North Am Small Anim Pract 2006; 36(3): 503-531.
35. Syed SA, Sherwani NZF, Riaz B, et al. Short-term effect of inhaled salbutamol on heart rate in healthy volunteers. Cureus 2021; 13(3): e13672. doi: 10.7759/ cureus.13672.
36. Guenther-Yenke CL, Rozanski EA. Terbutaline. In: Silverstein DC, Hopper K, (Eds). Small animal critical care medicine. 3rd ed. St. Louis, USA: Elsevier Saunders 2022; 1009-1011.
37. Lee H, Evans HE. Lack of cardiac effect from repeated doses of albuterol aerosol: a margin of safety. Clin Pediatr (Phila) 1986; 25(7): 349-352.
Veterinary Research Forum
Volume 17, Issue 8
August 2026
Pages 589-595

  • Receive Date 31 August 2025
  • Revise Date 14 December 2025
  • Accept Date 07 January 2026

Home

Guide for Authors

Submit Manuscript

Reviewers

Contact Us